Mount Yale Investment Advisors, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 241 filers reported holding TRANSMEDICS GROUP INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$640,520
-34.1%
11,699
+1.0%
0.07%
-32.0%
Q2 2023$972,488
+150.4%
11,580
+125.8%
0.10%
+134.1%
Q1 2023$388,419
+91.6%
5,129
+56.1%
0.04%
+91.3%
Q4 2022$202,7503,2850.02%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2023
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 325,000$27,293,5007.89%
Ophir Asset Management Pty Ltd 418,366$35,134,3777.32%
Sandhill Capital Partners LLC 812,844$68,262,6676.22%
Kent Lake Capital LLC 119,129$10,004,4534.60%
Eagle Health Investments LP 232,032$19,486,0473.64%
NEXT CENTURY GROWTH INVESTORS LLC 442,942$37,198,2693.58%
Bullseye Asset Management LLC 83,012$6,9713.50%
First Light Asset Management, LLC 377,464$31,699,4272.48%
Nicholas Investment Partners, LP 367,631$30,873,6512.11%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 671,716$56,410,7102.09%
View complete list of TRANSMEDICS GROUP INC shareholders